MET
MetLife
Financials · Life & Health Insurance · US
$84.49
Data:
✗ ETHICAL FAIL

WEAK MOAT
HIGH
Data Confidence: 100.0%
Key Metrics

How this company measures up on the fundamentals that matter

Market Cap
$50.2B
Total market value of the company
15.10
Reasonably valued
7.10
Based on estimated future earnings — lower means cheaper
Rev Growth
+2.7%
Year-over-year revenue change
Profit Margin
0.0%
How much profit the company keeps from each dollar of revenue
13.0%
Return on equity — how efficiently it uses shareholder money
Analyst Target
$90.31
+7% from current price — median analyst estimate
Recommendation
BUY
Consensus view from 16 analysts covering this stock
About MetLife

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it offers fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity and funded reinsurance solutions; credit insurance products; accident & health products covering hospitalization, cancer, critical illness, income protection, and scheduled medical reimbursement plans; and protection against long-term health care services. The company was incorporated in 1999 and is based in New York, New York.

https://www.metlife.com

Country: United States Employees: 46,000 Industry: Insurance - Life
Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity
FAIL
Core business does not involve prohibited activities
Debt Ratio
0.0%
Debt must be below 33% of total assets
Cash Ratio
0.0%
Interest-bearing cash below 33% of assets
Receivables
0.0%
Receivables below 49% of assets
Revenue Purity
0.0%
Non-compliant revenue below 5% — any excess requires purification
Valuation
$219.00
What our model estimates this business is worth per share
61.4%
Deep discount to fair value — significant undervaluation
Rating
AVOID
Overall assessment combining ethics, valuation, and quality
77.6th
Ranks in the top 22% of our 13,571 screened universe
Ethical Score
10.0
Valuation Score
95.0
Quality Score
41.0
Combined
46.9

Trading at $78 against a fair value of $219, a 64% discount. Fails ethical screen (Business activity screen). Ranks better than 68% of screened stocks.

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

ACCUMULATION
Smart money appears to be building positions quietly
0.551
Good returns relative to risk taken
0.0474
Modest edge detected — smaller position warranted
0.529
Acceptable balance between returns and drawdown risk
Annual Return
11.6%
Historical annualised return based on price data
-22.0%
Largest peak-to-trough decline — the worst it has been
BULL
Statistical model sees bullish momentum
Days in State
34
How long the current regime has persisted — longer means more stable
Market Data

Trading characteristics and market positioning

0.78
Less volatile than the market — more defensive
52W High
$83.85
-1% below the year high
52W Low
$67.33
25% above the year low
Avg Volume
3,691,319
Average daily shares traded — higher means easier to buy and sell
3.7
Days it would take all short sellers to cover — higher means more crowded
Short % Float
1.9%
Low short interest — limited bearish positioning
304.0%
Annual dividend as a percentage of the share price
$5.17
Earnings per share over the last 12 months
Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

1.42
Meaningful debt load — monitor closely
2.09
Strong balance sheet — comfortably covers short-term obligations
Quick Ratio
1.75
Like current ratio but excludes inventory — stricter test
Gross Margin
23.8%
Revenue left after cost of goods — higher means pricing power
Operating Margin
9.9%
Profit from core operations before interest and tax
$-17,429,749,760
Negative — the business is spending more than it generates
Revenue (TTM)
$77.6B
Total revenue over the last 12 months
Net Income
$3.4B
Profitable — the bottom line is positive
Analyst Coverage
Analysts
16
Target High
$106.00
Target Median
$90.31
Target Low
$75.00
Recent Insider Activity

SEC Form 4 filings — what company insiders are buying and selling

55
NEUTRAL
Mixed insider activity. 0 purchases and 0 sales in the last 90 days — no clear directional signal. Politicians have been buying this name.
Date Insider Title Type Shares Value
2026-04-30 O'NEILL ADRIENNE KAREN Officer 12,485
2026-04-01 MUMENTHALER CHRISTIAN STEPHANE Director 721 $51,314
2026-04-01 MCKENZIE DIANA L Director 721 $51,314
2026-04-01 WEINBERGER MARK A Director 721
2026-04-01 SEITZ MICHELLE Director 721
2026-04-01 HAY LAURA J Director 721 $51,314
2026-04-01 JOHNSON JEH CHARLES Director 721 $51,314
2026-04-01 HARRIS CARLA A Director 721 $51,314
2026-04-01 GLASER DANIEL S Director 721 $51,314
2026-04-01 MORRISON DENISE M Director 721
Source: SEC Form 4 filings via public data. View all insider activity at
Insider Intelligence
Political Trading Activity

Congressional trading disclosures involving this instrument

Date Politician Party Type Amount
21 Apr2026 Scott Peters Democrat buy 250K–500K
2026-05-05 Brian Babin Republican Sale 15K–50K
2026-04-24 Ro Khanna Democrat Purchase 1K–15K
2025-01-15 Tim Moore buy 15000
2024-11-10 Ted Cruz buy 15000
Source: Congressional disclosure filings. View all political trades at
Insider Intelligence
Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated:

Discover More
Alpha Insights Market Intelligence Titan Watch Ethical Screener Insider Intelligence Track Record Ethical Finance Zakat Calculator Iran Oil Tracker Foundry (292 articles) Indicators Join Free →

Get our weekly market brief free.